If you've spent late nights reading about menopause hormones, you've probably run into a comforting phrase: *bioidentical is natural, so it's safer.* It sounds reasonable. It's also one of the most misunderstood ideas in hormone care — and an independent provider will gently take it apart before building any plan with you.
This article is educational and not medical advice. The goal is to give you accurate, current framing so your conversation with a licensed provider starts on solid ground.
What 'bioidentical' actually means
"Bioidentical" describes hormones with a molecular structure identical to those your body makes — for example, 17β-estradiol and micronized progesterone. That's a real chemical fact, and it's a useful one. But here is the correction most people need: many FDA-approved menopause products are *already* bioidentical. Estradiol patches, gels, and micronized progesterone capsules are structurally identical to your own hormones and go through the full FDA review process [1][2].
So "bioidentical" is not a synonym for "compounded," and it is not a synonym for "natural," and it is definitely not a synonym for "safer." A molecule's structure tells you what it is. It does not tell you the dose, the purity, the consistency of what's in the bottle, or whether it's appropriate for your health history.
Source: [1] The 2022 Hormone Therapy Position Statement of The North American Menopause Society, [2] FDA: Menopause and Hormones — Common Questions, [3] National Academies: The Clinical Utility of Compounded Bioidentical Hormone Therapy
Where the confusion usually comes from
The phrase gets sticky because two different ideas got fused together in marketing:
1. Bioidentical structure (a scientific description that applies to many approved products).
2. Custom compounded "bioidentical hormone therapy" (cBHT) — hormones mixed by a compounding pharmacy, often marketed as personalized, "natural," and tailored to your saliva or blood levels.
The first is well studied. The second is where major medical bodies raise cautions. A 2020 report from the National Academies of Sciences, Engineering, and Medicine (NASEM) reviewed compounded hormone therapy and concluded there was insufficient evidence to support its safety and effectiveness, and discouraged its routine use when an approved alternative exists [3]. The Endocrine Society and the North American Menopause Society (now The Menopause Society) have echoed that custom compounding is not supported over approved options for most people [4][5].
Why 'natural' doesn't tell you what you think
Here's the part worth sitting with. Estradiol used in both approved and compounded products is often synthesized from plant sterols (soy, yam). "Natural" origin doesn't change the biology — your body cannot tell where a molecule started. And "natural" says nothing about the two things that matter most for safety: how much is in each dose and how consistent that amount is from batch to batch.
This is where oversight becomes concrete rather than abstract. FDA-approved hormone products must demonstrate consistent potency, purity, and stability. Compounded products are made per-prescription and are not reviewed or approved by the FDA for safety, effectiveness, or quality [6]. Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
There's a specific issue with salivary hormone "testing" that some cBHT programs use to justify custom formulas: professional societies note these levels don't correlate reliably with symptoms or tissue effects and shouldn't drive dosing [4][5].
What a provider actually weighs instead
A good hormone conversation skips the marketing and looks at *you*. For a woman navigating hot flashes, broken sleep, and brain fog — whether she's 43 and being told she's "too young" or 56 and told to "wait it out" — the provider is thinking about a few evidence-based anchors:
- Symptom picture and timing. Vasomotor symptoms (hot flashes, night sweats) are the most established reason clinicians consider hormone therapy [1][7].
- Time since menopause and age. Current guidance frames the benefit–risk balance as generally more favorable for symptomatic women who are under 60 or within about 10 years of menopause — the "timing hypothesis" [1][7]. Starting years in isn't automatically "too late," and being in perimenopause isn't automatically "too early"; it's individual.
- Your personal history. Blood clots, certain cancers, cardiovascular and liver history, and whether you have a uterus (which affects whether progesterone is part of the plan) all shape the decision [1][7].
- Route and formulation. Transdermal estradiol versus oral, and the type of progestogen, carry different considerations — decisions grounded in approved-product evidence, not compounding marketing [1][7].
The point of the correction isn't to scare you off hormones. It's the opposite: modern, balanced guidance often means there *is* a well-studied, approved path — and you don't have to accept an unregulated product to get it.
Source: [1] The 2022 Hormone Therapy Position Statement of The North American Menopause Society, [7] ACOG: Hormone Therapy in Primary Ovarian Insufficiency / Menopausal Hormone Therapy Guidance
Addressing the old fear-based headlines
Many women were frightened away from hormone therapy after early 2000s headlines. The nuance that got lost: those findings came largely from a specific population (older women, on average well past menopause) using specific oral formulations. Later analyses emphasized that age and time since menopause meaningfully change the risk picture, and that symptomatic women closer to menopause weigh a different balance [1][7]. You were right to want current information — and the science genuinely has matured.
years since menopause · marker = ~10-year mark
Source: [1] The 2022 Hormone Therapy Position Statement of The North American Menopause Society, [7] ACOG: Hormone Therapy in Primary Ovarian Insufficiency / Menopausal Hormone Therapy Guidance
The bottom line on the belief
"Bioidentical is natural, so it's safer" collapses three separate questions into one slogan. Structure, origin, and safety are different things. Many approved products are already bioidentical; "natural" origin doesn't guarantee purity or consistency; and custom compounding is specifically *not* endorsed over approved options by the major societies [3][4][5]. A provider's job is to translate all of that into a plan that fits your body, your history, and your stage of life.
Where Velri fits
Velri is a technology and coordination company — not a medical practice. Velri can help coordinate lab work and connect you with an independent, licensed provider who reviews your history and symptoms and decides, using their own clinical judgment, whether any therapy is appropriate. A prescription is never guaranteed. If a provider does prescribe, any medication is dispensed by an independent, licensed pharmacy. Where compounded options are ever discussed, remember: compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality; they are not equivalent to or interchangeable with any FDA-approved brand-name drug; and availability varies by state. This article is educational and does not replace a conversation with your own licensed provider.
